Dana Zinn
Family · Marshall, MONPI 1881132587
Payments from drug & device makers
Across 156 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$411
- Vanda Pharmaceuticals Inc.$322
- Johnson & Johnson$276
- AbbVie$197
- Neurocrine Biosciences, Inc.$197
- Alkermes, Inc.$180
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,806100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $411 |
| Vanda Pharmaceuticals Inc. | 13 | $322 |
| Johnson & Johnson | 18 | $276 |
| AbbVie | 9 | $197 |
| Neurocrine Biosciences, Inc. | 9 | $197 |
| Alkermes, Inc. | 9 | $180 |
| Otsuka America Pharmaceutical, Inc. | 10 | $179 |
| AstraZeneca | 9 | $156 |
| E.r. Squibb & Sons, L.L.C. | 11 | $153 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $139 |
| Organon | 6 | $98 |
| Indivior Inc. | 4 | $86 |
| Mylan Specialty L.p. | 2 | $51 |
| UCB, Inc. | 2 | $49 |
| Lundbeck LLC | 3 | $44 |
| Sun Pharmaceutical Industries Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Exact Sciences | 2 | $35 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Pfizer | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
How this compares
$2,806 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 14 | $54,698 |
| LinzessLinaclotide | 94 | $54,532 |
| EliquisApixaban | 81 | $47,624 |
| ProliaDenosumab | 22 | $40,737 |
| TrulicityDulaglutide | 40 | $39,793 |
| XifaxanRifaximin | 12 | $38,406 |
| JardianceEmpagliflozin | 60 | $35,021 |
| JanuviaSitagliptin Phosphate | 44 | $33,280 |
| XareltoRivaroxaban | 29 | $17,315 |
| FarxigaDapagliflozin Propanediol | 27 | $16,307 |
| AptiomEslicarbazepine Acetate | 13 | $15,974 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $15,171 |
| Victoza 3-PakLiraglutide | 17 | $14,010 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $13,532 |
| MyrbetriqMirabegron | 30 | $13,158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $411 | $54,69814 claims |
| AbbVieLinzess | $197 | $54,53294 claims |
| PfizerEliquis | $19 | $47,62481 claims |
| Lilly USA, LLCTrulicity | $15 | $39,79340 claims |
| Johnson & JohnsonXarelto | $276 | $17,31529 claims |
| AstraZenecaFarxiga | $156 | $16,30727 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $32 | $15,97413 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $13,15830 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $30 | $6,26312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.
Other family in Marshall
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.